Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Ethics and Transparency Committee on the Relationship Physician-Industry (CETREMI); suggestions to doctors in their relations with pharmaceutical industry].

Gaceta medica de Mexico·2016
Same author

Concordance of congenital heart defects in two pairs of monozygotic twins: pulmonary stenosis and tetralogy of Fallot.

Archivos de cardiologia de Mexico·2010
Same author

Anomalous origin of the left coronary artery from the pulmonary artery. Echocardiographic diagnosis.

Archivos de cardiologia de Mexico·2010
Same author

[Congenital coronary fistula. Clinical presentation in 7 cases and literature review].

Archivos de cardiologia de Mexico·2009
Same author

[The Fick method underestimates pulmonary flow calculation in patients subjected to bidirectional Glenn procedure].

Archivos de cardiologia de Mexico·2008
Same author

[Sequential segmental analysis in 100 cardiopulmonary specimens].

Archivos de cardiologia de Mexico·2007

Related Experiment Video

Updated: Jul 15, 2026

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

[Congenital aortic valve stenosis. Current treatment].

Carlos Alva1, Felipe David Gómez, Lucelly Yáñez Gutiérrez

  • 1Servicio de Cardiopatías Congénitas, Hospital de Cardiología, Centro Medico Nacional Siglo XXI, México, D.F. carlosalvaespinosa@yahoo.com.mx

Archivos De Cardiologia De Mexico
|May 2, 2007
PubMed
Summary

Congenital aortic valve stenosis, a common heart defect, has diverse treatments from fetal interventions to adult valve replacement. New techniques enhance pediatric valvuloplasty and the Ross procedure for specific cases.

More Related Videos

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

Related Experiment Videos

Last Updated: Jul 15, 2026

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position
11:20

A Rodent Model of The Ross Operation: Syngeneic Pulmonary Artery Graft Implantation in A Systemic Position

Published on: April 1, 2022

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model
05:31

Transcatheter Pulmonary Valve Replacement from Autologous Pericardium with a Self-Expandable Nitinol Stent in an Adult Sheep Model

Published on: June 8, 2022

Area of Science:

  • Cardiology
  • Pediatric Cardiac Surgery
  • Interventional Cardiology

Background:

  • Congenital aortic valve stenosis affects 5-7% of cardiac malformations, being the leading cause of left heart obstruction.
  • Treatment options have advanced across all age groups, from fetal interventions to adult percutaneous aortic valve replacement.
  • The Ross procedure is a primary treatment for children and young adults with hypoplastic aortic annuli.

Purpose of the Study:

  • To review current treatment modalities for congenital aortic valve stenosis.
  • To analyze the indications and optimal timing for various interventions.
  • To evaluate the outcomes associated with different treatment approaches.

Main Methods:

  • Review of existing medical literature on congenital aortic valve stenosis treatments.
  • Analysis of data on fetal interventions, percutaneous aortic valve replacement, percutaneous aortic valve valvuloplasty, and the Ross procedure.
  • Synthesis of information regarding indications, timing, and patient outcomes.

Main Results:

  • Fetal interventions represent an emerging treatment at the earliest stage of life.
  • Percutaneous aortic valve replacement is a viable option for elderly adults.
  • Advanced percutaneous aortic valve valvuloplasty techniques improve outcomes in children and adolescents.
  • The Ross procedure remains a preferred option for pediatric and young adult patients with hypoplastic aortic annuli.

Conclusions:

  • A spectrum of effective treatments for congenital aortic valve stenosis now exists, catering to different age groups and specific conditions.
  • Further review of indications, optimal timing, and outcomes is crucial for guiding clinical decision-making.
  • Continued research and refinement of these techniques promise improved patient management and long-term results.